galt
import
antigen
actinobacillu
pleuropneumonia
app
shown
provid
partial
protect
app
infect
previou
studi
lab
main
purpos
present
studi
investig
galt
induc
crossprotect
differ
app
serotyp
elucid
key
mechan
immun
respons
galt
antigen
stimul
bioinformat
analysi
demonstr
galt
highli
conserv
gene
app
wide
distribut
across
multipl
pathogen
strain
homolog
two
strain
rang
regard
galt
locu
indirect
enzymelink
immunosorb
assay
elisa
confirm
galt
specif
antibodi
could
induc
inactiv
app
whole
cell
bacterin
prepar
recombin
fusion
galt
protein
deriv
app
howev
proven
effect
crossprotect
antigen
app
sevorar
app
sevorar
histopatholog
examin
confirm
recombin
galt
vaccin
anim
show
less
sever
patholog
sign
lung
tissu
neg
control
app
challeng
immunohistochem
ihc
analysi
indic
infiltr
neutrophil
neg
group
significantli
increas
compar
normal
control
p
surviv
anim
decreas
compar
neg
group
antigalt
antibodi
shown
mediat
phagocytosi
neutrophil
interact
antigalt
antibodi
surviv
rate
app
challeng
vaccin
anim
significantli
reduc
p
studi
demonstr
galt
effect
crossprotect
antigen
could
use
potenti
vaccin
candid
multipl
app
serotyp
wen
x
et
al
uridyltransferas
galt
vivoinduc
antigen
actinobacillu
pleuropneumonia
serovar
strain
provid
immunoprotect
serovar
strain
plo
one
http
pig
contagi
pleuropneumonia
pcp
one
primari
diseas
respiratori
system
swine
caus
swine
cellulos
pleurisi
pneumonia
app
etiolog
agent
diseas
murin
model
app
respiratori
tract
infect
experiment
develop
evalu
efficaci
vaccin
accord
previou
studi
model
far
less
labori
resourc
intens
standard
porcin
model
serovar
report
past
sever
decad
new
serovar
report
tradit
protect
obtain
immun
serovarspecif
vaccin
typic
lack
cross
protect
abil
differ
serovar
result
vaccin
made
preval
serovar
within
given
region
proven
littl
use
area
differ
serovar
predomin
multival
inactiv
vaccin
app
incorpor
antigen
mani
serovar
thu
use
across
multipl
region
multival
vaccin
shown
provid
limit
cross
protect
partial
reduc
incid
diseas
improv
perform
first
gener
inactiv
vaccin
target
studi
recent
promis
vaccin
candid
cross
protect
antigen
typic
immunogen
marker
pathogen
highli
conserv
across
multipl
serovar
virul
factor
app
like
apx
toxin
lipopolysaccharid
capsular
polysaccharid
studi
crossprotect
vaccin
candid
apxi
apxii
apxiii
proven
provid
cross
protect
differ
app
serovar
apxiv
anoth
apx
toxin
possess
strong
antigen
properti
gene
conserv
across
known
serovar
app
recombin
rapxivn
shown
induc
high
level
antibodi
confer
strong
protect
challeng
differ
app
serovar
antigen
conserv
across
mani
serovar
given
pathogen
could
consid
potenti
compon
cross
protect
vaccin
develop
microbi
pathogen
isol
cultur
artifici
media
vitro
clinic
set
mani
virul
gene
includ
code
highli
antigen
virul
factor
induc
express
vivo
addit
vivo
studi
pathogen
host
provid
opportun
investig
humor
cellular
immun
respons
infect
mani
experiment
method
develop
studi
target
vivoinduc
gene
signaturetag
mutagenesi
stm
vivo
express
technolog
ivet
select
captur
transcrib
sequenc
scot
wide
use
screen
antigen
microbi
pathogen
technolog
proven
power
tool
effort
develop
cross
reactiv
vaccin
vivoinduc
ivi
antigen
play
import
role
virul
colon
host
ivi
protein
often
highli
antigen
highli
conserv
across
multipl
serovar
given
pathogen
make
ideal
candid
crossprotect
vaccin
uridyltransferas
galt
belong
gal
gene
cluster
product
enzym
involv
metabol
galactos
gene
involv
lp
core
biosynthesi
therefor
key
virul
factor
galt
app
vivoinduc
antigen
previou
studi
prove
protein
highli
immunogen
provid
partial
immun
protect
app
challeng
present
studi
crossprotect
mechan
immun
respons
galt
investig
mice
galt
induc
crossprotect
app
serovar
serovar
challeng
antigalt
serum
mediat
neutrophil
kill
function
galt
effect
crossprotect
antigen
potenti
vaccin
candid
prevent
pcp
anim
experi
perform
studi
approv
institut
anim
care
use
committe
sichuan
agricultur
univers
approv
number
six
eight
week
femal
balbc
mice
use
present
studi
purchas
chengdu
dossi
experiment
anim
co
ltd
anim
fed
food
water
ad
libitum
meanwhil
wood
wool
provid
nest
materi
anim
kept
check
daili
mice
euthan
immedi
end
anim
experi
host
anim
display
onset
sever
clinic
sign
app
infect
everi
effort
made
minim
anim
suffer
trypticas
soy
agar
tsa
trypicas
soy
broth
tsb
vv
fetal
calf
serum
use
app
strain
cultiv
nicotinamid
adenin
dinucleotid
nad
mgml
ad
growth
factor
app
refer
strain
purchas
china
institut
veterinari
drug
control
beij
china
app
isol
strain
store
maintain
lab
tabl
galt
express
strain
e
coli
petgalt
use
studi
transform
recombin
plasmid
construct
previou
studi
e
coli
cultur
luriabertani
lb
medium
kanamycin
mgml
app
strain
e
coli
strain
cultur
rpm
apxiva
gene
amplifi
pcr
app
refer
isol
strain
use
specif
primer
speci
identif
tabl
sequenc
galt
obtain
ncbi
conserv
sequenc
analyz
dnastar
softwar
use
design
primer
primer
galt
design
use
primer
premier
softwar
galt
gene
strain
amplifi
pcr
sequenc
qingk
biotech
chengdu
china
file
nucleotid
sequenc
galt
app
bacteria
genu
actinobacillu
analyz
use
galt
sequenc
via
blast
softwar
save
use
multipl
sequenc
align
ident
pair
nucleotid
sequenc
calcul
jotun
hein
method
use
megalign
program
use
construct
phylogenet
tree
galt
gene
studi
strain
phylogenet
tree
set
bootstrap
replic
neighborjoin
method
use
e
coli
petgalt
cultur
overnight
cultur
product
ad
new
lb
media
protein
express
iptg
mmoll
ad
cultur
reach
induct
anoth
hour
bacteria
collect
centrifug
g
min
prepack
lowpressur
chromatograph
cartridg
biorad
usa
use
studi
solut
prepar
accord
instruct
manual
bacteria
suspend
ml
buffer
biorad
usa
treat
ultrason
lysat
centrifug
g
min
supernat
collect
tag
fusion
protein
purif
galt
histag
fusion
protein
purifi
niaffin
chromatographi
purifi
recombin
protein
store
sixeight
week
balbc
mice
randomli
divid
four
group
prepar
polyclon
antibodi
group
vaccin
subcutan
phosphat
buffer
pb
plu
adjuv
formalininactiv
cfumic
plu
adjuv
formalininactiv
app
cfumic
plu
adjuv
galt
protein
plu
adjuv
denot
neg
control
group
group
group
galt
group
respect
freund
complet
adjuv
use
initi
immun
booster
immun
execut
two
week
later
freund
incomplet
adjuv
four
week
post
initi
immun
sera
differ
group
prepar
subpack
store
subsequ
protocol
vaccin
evalu
immun
protect
six
eight
week
femal
balbc
mice
randomli
divid
group
eight
mice
per
group
tabl
two
tabl
pcr
primer
sequenc
use
studi
galt
studi
http
tabl
detail
anim
immun
challeng
assay
group
immun
subcutan
galt
protein
plu
adjuv
two
group
neg
control
immun
subcutan
pb
plu
adjuv
normal
control
group
mice
challeng
serotyp
app
neg
control
group
consist
mice
given
pb
plu
adjuv
freund
complet
adjuv
freund
incomplet
adjuv
use
initi
booster
immun
boost
carri
initi
immun
interv
blank
serum
test
serum
sampl
two
week
post
vaccin
booster
collect
detect
igg
ld
app
determin
use
reedmuench
method
obtain
standard
challeng
dose
two
week
post
booster
pb
group
galt
protein
group
challeng
lethal
dose
app
respect
seven
day
continu
observ
follow
surviv
anim
note
indirect
enzymelink
immunosorb
assay
elisa
serum
immun
mice
examin
elisa
igg
level
brief
plate
coat
per
well
purifi
galt
recombin
protein
dilut
carbonatebicarbon
buffer
ph
overnight
well
wash
thrice
pbst
block
wv
bovin
serum
albumin
bsa
pbst
h
plate
wash
three
time
incub
sera
dilut
h
blank
serum
serum
week
post
initi
boost
immun
neg
group
group
group
galt
group
dilut
use
serum
diluent
ad
well
three
rins
goat
antimous
hrpigg
bioss
china
dilut
pb
use
secondari
antibodi
incub
h
plate
wash
three
time
pbst
tmb
ad
plate
incub
min
dark
rt
reaction
stop
h
absorb
well
read
wavelength
nm
use
elisa
reader
biorad
usa
histopatholog
lung
anim
differ
group
isol
fix
immers
neutral
formalin
immers
tissu
section
thick
hestain
evalu
histopatholog
use
olympu
microscop
olympu
japan
galt
immun
group
nonimmun
group
challeng
app
app
analyz
lung
tissu
healthi
mice
serv
normal
control
immunohistochemistri
analysi
standard
immunohistochem
ihc
method
conduct
analyz
neutrophil
macrophag
infiltr
tissu
differ
group
ihc
stain
monoclon
antibodi
mab
carri
paraffin
wax
section
obtain
differ
mous
lung
section
two
mab
use
rabbit
antimous
macrophag
rabbit
antimous
myeloperoxidas
mpo
neutrophil
section
treat
describ
stain
ihc
section
examin
photo
taken
ihc
photo
analyz
imagepro
plu
softwar
media
cybernet
inc
rockvil
md
usa
integr
optic
densiti
iod
photo
determin
posit
index
galt
immun
group
neg
group
challeng
app
app
analyz
neutrophil
macrophag
infiltr
lung
tissu
healthi
mice
treat
normal
control
ihc
result
analyz
use
ihc
mean
densiti
analysi
method
imagepro
plu
introduc
follow
section
field
magnif
select
randomli
photograph
isol
mice
bone
marrow
neutrophil
mice
bone
marrow
neutrophil
isol
use
mous
bone
marrow
neutrophil
isol
kit
haoyang
biolog
tianjin
china
mice
femur
isol
use
steril
techniqu
bone
marrow
fluid
wash
cleanout
fluid
anticoagul
ad
use
steril
syring
bone
marrow
suspens
centrifug
g
min
supernat
discard
care
cell
suspend
erythrocyt
sediment
liquid
cell
densiti
adjust
ml
ml
undilut
separ
medium
ml
separ
medium
ad
separ
medium
sampl
diluent
success
ml
centrifug
tube
bone
marrow
suspens
ad
ml
centrifug
tube
care
centrifug
min
centrifug
white
neutrophil
layer
extract
fivefold
volum
cleanout
fluid
ad
tube
contain
neutrophil
tube
centrifug
min
supernat
discard
erythrocyt
remov
use
erythrocyt
lysi
buffer
neutrophil
kill
assay
neutrophil
great
import
process
interact
bacteria
host
mous
neutrophil
kill
experi
carri
determin
whether
antigalt
sera
possess
opsonophagocytosi
effect
assay
carri
base
one
use
previou
studi
slight
modif
app
cultur
logarithm
growth
phase
wash
time
steril
pb
suspend
cultur
store
neutrophil
suspend
neutrophil
suspens
densiti
cellsml
ad
equal
volum
cfuml
app
antigalt
serum
blank
control
serum
neg
serum
mix
cell
final
concentr
bacteria
cultur
alon
use
control
incub
hour
cultur
dilut
steril
pb
spread
tsa
colonycount
percentag
bacteria
surviv
opsonophagocyt
kill
calcul
cfu
neutrophilscfu
without
neutrophil
statist
analys
data
analys
perform
spss
softwar
use
student
ttest
comparison
differ
differ
group
pvalu
consid
statist
differ
repres
asterisk
pvalu
repres
two
asterisk
ns
denot
signific
apxiva
gene
amplifi
pcr
app
strain
use
specif
primer
data
shown
also
use
specif
primer
galt
galt
gene
amplifi
pcr
app
strain
use
studi
fragment
bp
amplifi
app
strain
agaros
gel
electrophoresi
fig
multipl
sequenc
align
galt
sequenc
perform
among
app
isol
strain
refer
strain
use
megalign
softwar
galt
sequenc
nonapp
strain
actinobacillu
sui
strain
equuli
subsp
equuli
strain
includ
genebank
search
fig
galt
share
ident
app
strain
ident
two
strain
rang
among
app
strain
strain
actinobacillu
ident
galt
rang
sui
equuli
ident
galt
rang
short
galt
highli
conserv
among
app
strain
phylogenet
analys
app
galt
sequenc
perform
among
relat
sequenc
use
mega
softwar
fig
app
serovar
cluster
wide
differ
app
serotyp
differ
phylogenet
tree
app
serovar
isol
strain
china
wide
distribut
differ
branch
phylogenet
tree
meanwhil
app
serovar
isol
strain
app
serovar
refer
strain
shope
nt
branch
strain
isol
china
like
wide
distribut
differ
branch
sui
equuli
branch
next
app
serovar
strain
histag
galt
protein
induc
iptg
express
e
coli
fig
recombin
galt
protein
purifi
success
affin
chromatographi
size
protein
kilodalton
kda
fig
anim
immun
inact
whole
cell
recombin
protein
galt
pb
neg
control
anim
differ
group
immun
twice
twoweek
interv
serum
immun
week
week
post
initi
vaccin
serum
sampl
collect
igg
detect
plate
galt
igg
detect
coat
recombin
protein
galt
serum
differ
group
test
presenc
igg
indirect
elisa
neg
control
group
galt
specif
igg
anim
protect
challeng
post
immun
recombin
protein
galt
tabl
anim
neg
control
group
die
acut
challeng
tabl
although
galt
deriv
partial
protect
provid
galt
challeng
strain
tabl
galt
also
show
abil
protect
challeng
virul
serovar
histopatholog
examin
use
analyz
protect
effect
galt
immun
challeng
lung
tissu
mice
neg
control
group
underw
sever
patholog
chang
compar
normal
control
group
fig
structur
pulmonari
alveoli
lung
tissu
challeng
mice
neg
group
damag
heavi
edemat
lesion
observ
lung
parenchyma
fig
addit
lung
tissu
neg
control
anim
show
inflamm
infiltr
neutrophil
normal
control
group
final
tissu
surviv
anim
galt
immun
group
moder
inflamm
infiltr
mix
mononuclear
cell
neutrophil
fig
susceptibleuntr
mice
show
sever
clinic
sign
labor
respir
app
challeng
administ
show
clinic
sign
indic
app
infect
euthan
immedi
mice
show
mild
clinic
sign
kept
aliv
end
experiment
trial
macroscop
observ
lung
neg
control
mice
show
sever
lung
lesion
edema
hemorrhag
cyanosi
lung
surviv
mice
galt
immun
group
similar
normal
control
challeng
app
infiltr
neutrophil
lung
tissu
two
group
significantli
greater
normal
control
fig
mean
densiti
neutrophil
infiltr
much
higher
challeng
neg
control
normal
control
p
fig
app
challeng
galt
immun
group
infiltr
neutrophil
lung
tissu
surviv
anim
less
neg
control
fig
compar
mean
densiti
neg
control
galt
immun
group
display
significantli
reduc
neutrophil
infiltr
fig
result
ihc
analysi
macrophag
indic
signific
differ
normal
group
challeng
group
file
surviv
rate
app
incub
antigalt
antibodi
significantli
reduc
compar
neg
control
serum
pb
immun
serum
p
fig
compar
surviv
rate
blank
neg
control
surviv
rate
galt
group
reduc
indic
oposon
phagocytosi
neutrophil
could
effici
induc
antigalt
antibodi
app
one
import
bacteri
pathogen
swine
studi
sever
decad
app
caus
sever
respiratori
system
diseas
swine
high
mortal
rate
galt
vivoinduc
antigen
actinobacillu
pleuropneumonia
provid
cross
immunoprotect
incur
signific
econom
loss
swine
agronomi
worldwid
antibacteri
agent
view
first
choic
treat
diseas
caus
bacteria
howev
report
abus
overus
antibacteri
agent
select
evergrow
popul
resist
pathogen
includ
app
use
vaccin
proven
better
choic
effort
control
pcp
outbreak
apart
use
tradit
inactiv
vaccin
mani
studi
focus
new
vaccin
control
pcp
galt
demonstr
effici
antigen
app
could
taken
potenti
vaccin
candid
differ
app
serovar
isol
strain
use
studi
analyz
crossprotect
effect
recombin
protein
galt
present
studi
demonstr
recombin
galt
protein
app
serovar
strain
cross
protect
app
serovar
strain
challeng
bioinformat
analysi
show
galt
gene
highli
conserv
wide
distribut
differ
app
strain
make
promis
candid
basi
cross
protect
vaccin
result
phylogenet
analysi
demonstr
almost
app
strain
distribut
one
phylogenet
branch
howev
classifi
small
side
branch
similar
two
app
strain
studi
rang
report
plpb
across
differ
p
multocida
strain
exhibit
high
level
homolog
mice
antirplpb
sera
crossreact
sever
p
multocida
strain
outer
membran
protein
f
ompf
gene
escherichia
coli
strain
share
ident
select
e
coli
shigella
strain
immunolog
test
show
recombin
ompf
induc
effect
immun
respons
provid
protect
multistrain
challeng
outer
membran
protein
lamb
vibrio
alginolyticu
also
demonstr
effect
cross
protect
antigen
show
crossreact
apfa
vacj
pala
app
also
studi
potenti
vaccin
candid
howev
antigen
could
induc
antigen
specif
antibodi
fail
induc
protect
challeng
present
studi
recombin
galt
protein
deriv
provid
partial
protect
challeng
protect
qualiti
galt
may
also
exist
serovar
serovar
galt
could
induc
high
level
antibodi
respons
indic
antigen
high
immunogen
properti
immun
anim
inactiv
wholecel
app
elicit
galt
specif
antibodi
therefor
galt
may
use
diagnost
antigen
differenti
anim
infect
expos
app
vaccin
agent
infect
sera
vs
vaccin
sera
studi
result
ihc
analysi
demonstr
infiltr
neutrophil
neg
control
challeng
group
signific
higher
normal
control
earli
stage
infect
meanwhil
immun
group
infiltr
neutrophil
lower
neg
control
lesion
caus
app
character
necrosi
hemorrhag
neutrophil
infiltr
earli
stage
follow
vascular
thrombosi
edema
macrophag
infiltr
fibrin
pleurisi
acut
inflammatori
respons
neutrophil
import
effector
cell
serv
clear
extracellular
pathogen
neutrophil
predomin
inflammatori
cell
infiltr
alveolar
space
earli
app
infect
antigalt
serum
induc
phagocytosi
neutrophil
therebi
stimul
innat
immun
respons
process
app
infect
fig
neutrophil
major
cell
type
innat
immun
respons
act
primari
line
defens
invad
microbi
pathogen
profession
phagocyt
function
neutrophil
engulf
kill
clearanc
bacteria
addit
neutrophil
involv
activ
regul
effector
function
innat
adapt
immun
cell
demonstr
galt
provid
immun
protect
murin
model
confer
partial
cross
protect
heterolog
app
sevorar
galt
highli
conserv
gene
distribut
throughout
refer
strain
well
isol
strain
use
studi
sequenc
galt
conserv
ident
app
strain
analyz
rang
galt
specif
antibodi
could
detect
immun
sera
anim
vaccin
inactiv
app
anim
neg
control
group
die
rapidli
challeng
immun
group
provid
partial
protect
demonstr
immun
recombin
galt
appsevorar
strain
confer
cross
protect
heterolog
app
serovar
histopatholog
ihc
analysi
demonstr
tissu
damag
allevi
infiltr
neuthophil
anim
lung
tissu
reduc
post
immun
applic
galt
vaccin
addit
bacteri
phagocytosi
neutrophil
found
significantli
promot
galt
specif
antibodi
present
studi
demonstr
function
galt
protein
murin
model
import
initi
step
vaccin
prepar
trial
futur
potenti
vaccin
candid
use
present
studi
test
protect
efficaci
pig
